Nicoleta Radu | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Nicoleta Radu | Pharmaceutical Science | Best Researcher Award

Dr. Sc HDR at USAMV B & INCDCP, Romania

Dr. Radu Nicoleta is an accomplished scientist and educator specializing in biotechnology and engineering sciences. With over two decades of experience in research, education, and development, she has made significant contributions to these fields. Currently an Associate Professor at the Doctoral School of Biotechnology, University of Agronomic Sciences and Veterinary Medicine of Bucharest, she is dedicated to advancing knowledge through teaching and mentoring doctoral students. Dr. Radu has also held leadership roles, such as Head of the Education and Bioethics Commission at the Romanian Society of Bioengineering and Biotechnology, showcasing her commitment to ethics and education in science. Her expertise spans medical biotechnology, bioengineering, and entrepreneurship, with an impressive publication record in reputable journals. As a trusted evaluator for prestigious programs like the EU, COST, and EUREKA, she plays a vital role in shaping the research landscape. Her dedication to innovation, teaching, and interdisciplinary research highlights her as a distinguished figure in biotechnology and life sciences.

Professional Profile

Education

Dr. Radu Nicoleta has a robust academic foundation in engineering and life sciences. She earned her Ph.D. in Engineering Science in 2005 from the University POLITEHNICA of Bucharest, demonstrating her expertise in advanced engineering applications. Prior to her doctorate, she obtained two Master’s degrees: one in Inorganic Chemistry in 1995 and another in Biotechnology in 2010, both from the University POLITEHNICA of Bucharest. Her education reflects a multidisciplinary approach, combining chemistry, engineering, and biotechnology. Additionally, she holds a Bachelor’s degree in Engineering Science, awarded in 1994. Dr. Radu’s academic pursuits also include a postdoctoral fellowship in Medical Biotechnology in 2011, conducted at the University of Agricultural Science and Veterinary Medicine Cluj Napoca and University POLITEHNICA of Bucharest. Her comprehensive educational background underpins her expertise in integrating engineering and life sciences, shaping her as a leader in research and education.

Professional Experience

Dr. Radu Nicoleta boasts an extensive professional career spanning academic and industrial sectors. She currently serves as an Associate Professor at the Doctoral School of Biotechnology, University of Agronomic Sciences and Veterinary Medicine of Bucharest, where she focuses on advanced education in biotechnology. Since 2001, she has been a Scientist at the Biotechnology Department of INCDCP Bucharest, contributing significantly to research and development in life sciences. Between 2008 and 2020, she chaired the Education and Bioethics Commission of the Romanian Society of Bioengineering and Biotechnology, promoting ethical practices and interdisciplinary education. Earlier in her career, she worked as a Designer and Project Manager at IITPIC Bucharest, leading engineering and research projects in the chemical industry from 1995 to 2001. Her career reflects a seamless blend of academia, research, and industry, showcasing her adaptability and expertise across diverse professional environments.

Research Interests

Dr. Radu Nicoleta’s research interests lie at the intersection of biotechnology, life sciences, and engineering sciences. She focuses on advancing medical biotechnology, with applications in healthcare, agriculture, and sustainable development. Her work encompasses bioengineering innovations, emphasizing entrepreneurship and modern learning methods. Dr. Radu is particularly interested in integrating biotechnological advancements with ethical considerations to address global challenges. Her multidisciplinary approach includes projects in bioprocess engineering, molecular biotechnology, and the development of innovative educational tools. She is also involved in fostering collaborations between academia and industry to translate research into practical solutions. By bridging engineering and life sciences, Dr. Radu’s research aims to contribute to technological progress and societal well-being.

Research Skills

Dr. Radu Nicoleta is a highly skilled researcher with expertise in a wide range of methodologies and tools. She is proficient in statistical modeling and computational analysis, using software such as Fuzzy Tech, Neural Networks, Table Curve, and Origin. Her technical capabilities include advanced research in engineering and life sciences, particularly in molecular and bioengineering techniques. As an educator and mentor, she is adept at designing and conducting experiments, managing multidisciplinary projects, and utilizing modern teaching technologies. Dr. Radu’s competencies extend to scientific writing, with experience in authoring books and research articles. Additionally, her multilingual abilities (English, French, and Romanian) enable her to engage effectively in international collaborations, review scholarly work, and contribute to global research networks.

Awards and Honors

Dr. Radu Nicoleta’s contributions to science and education have been widely recognized. She has served as an evaluator for prestigious research programs, including the EU Programme, COST, EUREKA, and INNOWIDE. Her role in these programs underscores her expertise in assessing cutting-edge research and fostering innovation. As a reviewer for numerous high-impact journals across disciplines such as pharmacology, oncology, biotechnology, and education, Dr. Radu has established herself as a trusted authority in her field. Her leadership in the Romanian Society of Bioengineering and Biotechnology has been instrumental in advancing bioethics and education. These accolades, combined with her extensive publication record, highlight her achievements and dedication to excellence in research and education.

Conclusion 🏆

Dr. Radu Nicoleta is a strong candidate for the Best Researcher Award based on her extensive experience, academic credentials, and significant contributions to biotechnology and engineering sciences. Her leadership roles, evaluation expertise, and dedication to education further solidify her candidacy. However, focusing on impactful research publications, global collaborations, and showcasing recent innovative contributions would elevate her profile even more for such prestigious recognition. Overall, her profile aligns well with the criteria for the award.

Publication Top Notes

  1. Cladosporium sp. Isolate as Fungal Plant Growth Promoting Agent
    Authors: I. Răut, M. Călin, L. Capră, A.M. Gurban, M. Doni, N. Radu, L. Jecu
    Journal: Agronomy
    Year: 2021
    Citations: 56
  2. Fungal Based Biopolymer Composites for Construction Materials
    Authors: I. Răut, M. Călin, Z. Vuluga, F. Oancea, J. Paceagiu, N. Radu, M. Doni, et al.
    Journal: Materials
    Year: 2021
    Citations: 38
  3. Antimicrobial Effect of Monascus purpureus Red Rice Against Some Bacterial and Fungal Strains
    Authors: M. Ferdes, C. Ungureanu, N. Radu, A.A. Chirvase
    Journal: New Biotechnology
    Year: 2009
    Citations: 28
  4. The Effect of Resveratrol or Curcumin on Head and Neck Cancer Cells Sensitivity to the Cytotoxic Effects of Cisplatin
    Authors: M. Bostan, G.G. Petrică-Matei, N. Radu, R. Hainarosie, C.D. Stefanescu, et al.
    Journal: Nutrients
    Year: 2020
    Citations: 22
  5. Cisplatin Effect on Head and Neck Squamous Cell Carcinoma Cells is Modulated by ERK1/2 Protein Kinases
    Authors: M. Bostan, G.G. Petrică-Matei, G. Ion, N. Radu, M. Mihăilă, R. Hainăroşie, et al.
    Journal: Experimental and Therapeutic Medicine
    Year: 2019
    Citations: 22
  6. Ganoderma lucidum-Mediated Green Synthesis of Silver Nanoparticles with Antimicrobial Activity
    Authors: M. Constantin, I. Răut, R. Suica-Bunghez, C. Firinca, N. Radu, A.M. Gurban, et al.
    Journal: Materials
    Year: 2023
    Citations: 21
  7. Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines
    Authors: M. Bostan, M. Mihăilă, G.G. Petrică-Matei, N. Radu, R. Hainarosie, et al.
    Journal: International Journal of Molecular Sciences
    Year: 2021
    Citations: 21
  8. Studies Regarding the Pharmaceutical Potential of Derivative Products from Plantain
    Authors: M.G.O. Zaharie, N. Radu, L. Pirvu, M. Bostan, M. Voicescu, M. Begea, et al.
    Journal: Plants
    Year: 2022
    Citations: 15
  9. Entrepreneurship in the Field of Life Sciences: The Personal Skills Needed to Start an Innovative SME
    Authors: N. Radu, A.A. Chirvase, N. Babeanu, M. Begea
    Year: 2019
    Citations: 14
  10. Biomaterials Obtained from Probiotic Consortia of Microorganisms: Potential Applications in Regenerative Medicine
    Authors: N. Radu, V. Roman, C. Tănăsescu
    Journal: Molecular Crystals and Liquid Crystals
    Year: 2016
    Citations: 14

 

Justine Benevent | Pharmaceutical Science | Best Scholar Award

Posted on by ScienceFather

Dr. Justine Benevent | Pharmaceutical Science | Best Scholar Award

MCU-PH at CHU Toulouse, INSERM CERPOP, France

Based on the provided information, Justine Benevent appears to be a strong candidate for the Best Scholar Award. Here is a detailed assessment of her suitability, structured by various criteria:

Education

Justine Benevent’s educational background is distinguished by a series of advanced degrees in pharmacology and related fields. She holds a Diplôme d’état de Docteur en Pharmacie from Bordeaux, providing a comprehensive foundation in pharmacy. She further specialized with a DESC de Pharmacologie médicale from Bordeaux, focusing on medical pharmacology. Her academic journey continued with a Thèse d’Université de Pharmacologie in Toulouse, where she engaged in in-depth research. She also earned a Diplôme Universitaire de pédagogie en Santé from Toulouse, enhancing her skills in health education. Additionally, she completed the DES Pharmacie hospitalière from Bordeaux, highlighting her expertise in hospital pharmacy. These qualifications reflect her extensive training and dedication to the field of pharmacology, underpinning her expertise and contributions to research and clinical practice.

Research Contributions

Justine Benevent has made significant research contributions in pharmacology, with a focus on medications, reproduction, pregnancy, and breastfeeding. She has a solid publication record with 33 papers, including 6 as the first author, and a notable h-index of 10, indicating her research impact and recognition in the academic community.

Geographic Impact

Her research has a wide geographic impact, involving collaborations with international institutions such as PharmaSafe at the University of Oslo, Norway. Her work with the European Consortium IMI ConcePTION highlights her ability to engage in research that transcends national boundaries, addressing health issues relevant to diverse populations.

Collaborative Efforts

Justine Benevent is actively involved in several collaborative research projects and networks. She is a partner of the European Consortium IMI ConcePTION, a member of the national network REGARDs, and participates in various working groups, including those focused on mental health and reproductive risks of drugs. These collaborations demonstrate her commitment to multi-disciplinary and international research efforts.

Applied Research

Her research is highly applied, focusing on real-world health issues such as the effects of medications during pregnancy and breastfeeding. Her role in the project “Maison des Femmes” at CHU de Toulouse, aimed at improving healthcare for women, underscores her dedication to applying research findings to enhance community health and well-being.

Specific Projects and Publications

Justine Benevent has led and contributed to numerous impactful projects. Her work within the “Santé périnatale, pédiatrique et des adolescents” team at CERPOP addresses critical aspects of perinatal and pediatric health. She has also been involved in leading two projects within the IMI ConcePTION consortium, further highlighting her leadership in significant research initiatives.

Environmental Health

While her primary focus is on pharmacology and reproductive health, her work indirectly impacts environmental health by addressing the safe use of medications during critical periods such as pregnancy and breastfeeding. This contributes to overall community health by ensuring safer pharmaceutical practices.

Vector Control

There is no direct mention of research in vector control in her profile. However, her extensive work in pharmacology and drug safety may intersect with public health strategies that could include elements of vector control indirectly.

Waste Management and Water Quality

Justine Benevent’s profile does not indicate direct involvement in waste management and water quality research. Her expertise lies primarily in pharmacology and clinical research methodology.

Parasitology and Infectious Diseases

Although parasitology and infectious diseases are not explicitly mentioned, her pharmacological research, especially in the context of reproductive health, could contribute to understanding and managing infections that affect pregnant women and infants.

Awards and Recognition

Justine Benevent’s academic and research achievements have been recognized through various positions and memberships, such as her role as Treasurer of the CNPM (Collège National de Pharmacologie Médicale) and her involvement in the French Society of Pharmacology and Therapeutics (SFPT). Her significant publication record and citation count further attest to her recognition in the field.

Conclusion

Justine Benevent is a highly accomplished scholar with a strong background in pharmacology, evidenced by her extensive research contributions, collaborative efforts, and applied research impact. Her work addresses crucial health issues related to medications and reproductive health, making her a deserving candidate for the Best Scholar Award. Her leadership in various national and international research projects and her dedication to improving community health through applied research are particularly commendable.

Publications Top Notes

  1. Teaching pharmacovigilance to French medical students during the COVID-19 pandemic: Interest of distance learning clinical reasoning sessions
    • Authors: F. Montastruc, F. Muscari, I. Tack, G. Durrieu, A. Sommet
    • Year: 2024
  2. Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: A systematic review and meta-analysis
    • Authors: L. Saint-Lary, J. Benevent, C. Damase-Michel, V. Leroy, A. Sommet
    • Year: 2023
    • Citations: 2
  3. Drug monitoring in pregnant women: about the Regards network | Surveillance des médicaments chez les femmes enceintes : à propos du réseau Regards
    • Authors: I. Lacroix, M. Araujo, A. Caillet, L. Delteil, C. Damase-Michel
    • Year: 2023
    • Citations: 1
  4. Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database
    • Authors: J. Benevent, M. Araujo, S. Karki, S. Tebeka, C. Damase-Michel
    • Year: 2023
    • Citations: 2
  5. Adverse drug reactions in pregnant women: Do they differ from those in non-pregnant women of childbearing age?
    • Authors: M. Balon, S. Tessier, C. Damase-Michel, J. Benevent, I. Lacroix
    • Year: 2023
    • Citations: 5
  6. First trimester pregnancy exposure to fosfomycin and risk of major congenital anomaly: a comparative study in the EFEMERIS database
    • Authors: J. Benevent, M. Araujo, A.-B. Beau, I. Lacroix, C. Damase-Michel
    • Year: 2023
    • Citations: 3
  7. Interactions between antiseizure medications and contraception: A study about the knowledge of patients and their specialist physicians
    • Authors: A. Gosset, M. Denuelle, L. Valton, B.énévent, F. Tremollières
    • Year: 2022
    • Citations: 5
  8. Prenatal Drug Exposure in Children With a History of Neuropsychiatric Care: A Nested Case-Control Study
    • Authors: J. Benevent, C. Hurault-Delarue, M. Araujo, I. Lacroix, C. Damase-Michel
    • Year: 2022
  9. What changes in prescription patterns of antiemetic medications in pregnant women in France?
    • Authors: C. Hurault-Delarue, M. Araujo, C. Vabre, C. Damase-Michel, I. Lacroix
    • Year: 2021
    • Citations: 4
  10. Maternal Medication Use and Childhood Cancer in Offspring-Systematic Review and Considerations for Researchers
    • Authors: S. Hjorth, C.H. Hemmingsen, J. Benevent, M. Hargreave, H. Nordeng
    • Year: 2021
    • Citations: 2

 

 

Xin Wang | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Xin Wang | Pharmaceutical Science | Best Researcher Award

Assoc. Professor and PhD supervisor of Shanghai Jiao Tong University, China.

Xin Wang is a Tenure-Track Associate Professor at Shanghai Jiao Tong University, specializing in pharmaceutical and biomedical analysis. He earned his Ph.D. in Analytical Chemistry from Peking University and completed postdoctoral work at MIT and UC Berkeley. His research focuses on mass spectrometry, metabolomics, and proteomics, with key projects including drug metabolism analysis, human neurogenesis studies, and advanced sample preparation techniques. Wang’s contributions have garnered several awards, such as the Shanghai Pujiang Talent Plan Award and recognition at MIT. His expertise in analytical techniques and innovative methods has significantly impacted both academic research and industry practices.

Professional Profiles:

Education

Xin Wang completed his B.Sc. in Chemistry at Wuhan University, China, in 2010. He pursued his Ph.D. in Analytical Chemistry at Peking University, graduating in 2015. Following his doctoral studies, Dr. Wang undertook postdoctoral research at the Massachusetts Institute of Technology (MIT) from 2015 to 2018. Since 2020, he has been serving as a Tenure-Track Associate Professor at the School of Pharmaceutical Sciences, Shanghai Jiao Tong University, China.

Professional Experience

Xin Wang’s professional experience includes a significant role as a Tenure-Track Associate Professor at the School of Pharmaceutical Sciences, Shanghai Jiao Tong University, where he has been since 2020. Before this, he was a Senior Postdoctoral Associate at MIT’s Department of Biological Engineering from 2018 to 2019, and a Postdoctoral Associate in the same department from 2015 to 2018. His earlier academic journey includes a Ph.D. in Analytical Chemistry from Peking University, where he also worked as a Visiting Graduate Student at UC Berkeley.

Research Interest

Xin Wang’s research interests are at the forefront of pharmaceutical and biomedical analysis, emphasizing the use of advanced analytical techniques. His work primarily focuses on mass spectrometry and its applications in drug metabolism and toxicity testing, aiming to replace traditional trials with in vitro human systems. He is also deeply engaged in metabolomics and proteomics, using these techniques to unravel metabolic features in human neurogenesis and other physiological processes. Wang has developed innovative methods in solid-phase microextraction to enhance the sensitivity and accuracy of analyzing low-molecular-mass compounds. His research integrates these areas to advance understanding in drug testing, biomarker discovery, and the mechanistic insights into human health and disease. This multidisciplinary approach not only pushes the boundaries of analytical chemistry but also contributes to more effective and efficient drug development and disease treatment strategies.

Award and Honors

Xin Wang has received several prestigious awards and honors throughout his career. In 2023, he was recognized as an Outstanding Individual with Exceptional Contributions in Education by the School of Pharmacy at Shanghai Jiao Tong University. He also won the Second Prize in the Young Professor Teaching Skills Competition at Shanghai Jiao Tong University in 2022. Wang’s accolades include the Shanghai Overseas High-Level Talent Program Award and the Shanghai Pujiang Talent Plan Award, both in 2020. In 2016, he earned First Place in the MIT Center for Environmental Health Sciences Session. Additionally, he was awarded the First Prize in the Science and Technology Award from the China Association for Instrumental Analysis in 2015. Earlier achievements include the Aoqing Tang Scholarship (2015), the Brilliance Scholarship (2014), and multiple awards for his graduate research and innovation.

Research Skills

Xin Wang possesses advanced research skills in several key areas of analytical and biomedical science. His expertise includes pharmaceutical and biomedical analysis, utilizing techniques such as mass spectrometry, metabolomics, and proteomics to study complex biological systems. He is proficient in solid-phase microextraction and has developed innovative methods for capturing and quantifying low-molecular-mass compounds. Wang’s work with time-dependent metabolomics and LC-MS-based quantitation reflects his ability to apply cutting-edge analytical techniques to understand human neurogenesis and drug metabolism. His research in automated sample preparation and ambient mass spectrometry demonstrates his skills in developing novel methodologies for high-sensitivity detection and analysis. Wang’s contributions to bioanalytical strategies and experimental design have been recognized and published in top scientific journals, showcasing his ability to push the boundaries of current research methodologies.

Publications

  1. “Mass spectrometry‐based metabolomics for the investigation of antibiotic–bacterial interactions”
    • Authors: Xin Wang
    • Year: 2024
  2. “A new approach towards highly sensitive detection of endogenous N-acetylaspartic acid, N-acetylglutamic acid, and N-acetylaspartylglutamic acid in brain tissues based on strong anion exchange monolith microextraction coupled with UHPLC-MS/MS”
    • Authors: Xin Wang
    • Year: 2024
  3. “Mass spectrometry-based quantitation combined with time-dependent metabolomics to discover metabolic features in human neurogenesis using neural constructs generated from neural progenitor cells”
    • Authors: Xin Wang
    • Year: 2023
  4. “Mass spectrometry analysis of S-nitrosylation of proteins and its role in cancer, cardiovascular and neurodegenerative diseases”
    • Authors: Xin Wang
    • Year: 2022
  5. “Low Doses of Arsenic in a Mouse Model of Human Exposure and in Neuronal Culture Lead to S-Nitrosylation of Synaptic Proteins and Apoptosis via Nitric Oxide”
    • Authors: Xin Wang
    • Year: 2020
  6. “Analysis of an Integrated Human Multiorgan Microphysiological System for Combined Tolcapone Metabolism and Brain Metabolomics”
    • Authors: Xin Wang
    • Year: 2019
  7. “Automated Online Solid-Phase Derivatization for Sensitive Quantification of Endogenous S-Nitrosoglutathione and Rapid Capture of Other Low-Molecular-Mass S-Nitrosothiols”
    • Authors: Xin Wang
    • Year: 2018
  8. “Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function”
    • Authors: Xin Wang
    • Year: 2018
  9. “Fast analysis of glycosides based on HKUST-1-coated monolith solid-phase microextraction and direct analysis in real-time mass spectrometry”
    • Authors: Xin Wang
    • Year: 2017
  10. “Polymer‐based monolithic column with incorporated chiral metal–organic framework for enantioseparation of methyl phenyl sulfoxide using nano‐liquid chromatography”
    • Authors: Xin Wang
    • Year: 2016